HealthDay News — Hypertensive disorders of pregnancy (HDP) are associated with modestly increased risks for autism spectrum disorders (ASDs) and possibly attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a study published online March 22 in JAMA Pediatrics.
Judith S. Brand, PhD, from Örebro University in Sweden, and colleagues used data from the Medical Birth Register, as well as 2 cohorts — a birth cohort of 1,085,024 individuals born between 1987 and 1996 and followed through 2014 and 285,901 men born between 1982 and 1992 who attended assessments for military conscription — to assess the relationship between HDP and neurodevelopmental outcomes in offspring.
The researchers found that the prevalence of maternal HDP was 4% in the birth cohort and 5.1% in the military conscription cohort, while 15,858 participants received a diagnosis of ASD, 36,852 a diagnosis of ADHD, and 8454 a diagnosis of intellectual disability (ID). In whole-cohort analyses, HDP were associated with offspring ASDs (hazard ratio [HR], 1.22; 95% CI, 1.13-1.31), ADHD (HR, 1.10; 95% CI, 1.05-1.16), and ID (HR, 1.39; 95% CI, 1.27-1.53). Though less statistically powered, analyses suggested similar estimates for ASDs (HR, 1.19; 95% CI, 1.00-1.42) and possibly ADHD (HR, 1.09; 95% CI, 0.95-1.24), but not for ID (HR, 1.04; 95% CI, 0.83-1.29), when comparing siblings discordant for HDP. Additionally, HDP were associated with somewhat lower cognitive scores in the whole-cohort analysis (mean difference comparing offspring exposed with those unexposed, -0.10; 95% CI, -0.13 to -0.07), but when comparing siblings, the association was null (mean difference, 0.00; 95% CI, -0.09 to 0.08).
“The study results suggest that HDP are associated with small increased risks of ASDs and possibly ADHD in offspring, whereas associations with ID and cognitive performance are likely confounded by shared familial (environmental or genetic) factors,” the authors write.
One author disclosed financial ties to the pharmaceutical industry.